Please use this identifier to cite or link to this item:
Title: COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup
Author: Nadim, Mitra K.
Forni, Lui G.
Mehta, Ravindra L.
Connor Jr., Michael J.
Liu, Kathleen D.
Ostermann, Marlies
Rimmele, Thomas
Zarbock, Alexander
Bell, Samira
Bihorac, Azra
Cantaluppi, Vincenzo
Hoste, Eric
Husain-Syed, Faeq
Germain, Michael J.
Goldstein, Stuart L.
Gupta, Shruti
Joannidis, Michael
Kashani, Kianoush
Koyner, Jay L.
Legrand, Matthieu
Lumlertgul, Nuttha
Mohan, Sumit
Pannu, Neesh
Peng, Zhiyong
Pérez Fernández, Xose L.
Pickkers, Peter
Prowle, John
Reis, Thiago
Srisawat, Nattachai
Tolwani, Ashita
Vijayan, Anitha
Villa, Gianluca
Yang, Li
Ronco, Claudio
Kellum, John A.
Keywords: COVID-19
Insuficiència renal aguda
Acute renal failure
Issue Date: 1-Dec-2020
Publisher: Nature Research
Abstract: Kidney involvement in patients with coronavirus disease 2019 (COVID-19) is common, and can range from the presence of proteinuria and haematuria to acute kidney injury (AKI) requiring renal replacement therapy (RRT; also known as kidney replacement therapy). COVID-19-associated AKI (COVID-19 AKI) is associated with high mortality and serves as an independent risk factor for all-cause in-hospital death in patients with COVID-19. The pathophysiology and mechanisms of AKI in patients with COVID-19 have not been fully elucidated and seem to be multifactorial, in keeping with the pathophysiology of AKI in other patients who are critically ill. Little is known about the prevention and management of COVID-19 AKI. The emergence of regional 'surges' in COVID-19 cases can limit hospital resources, including dialysis availability and supplies; thus, careful daily assessment of available resources is needed. In this Consensus Statement, the Acute Disease Quality Initiative provides recommendations for the diagnosis, prevention and management of COVID-19 AKI based on current literature. We also make recommendations for areas of future research, which are aimed at improving understanding of the underlying processes and improving outcomes for patients with COVID-19 AKI.
Note: Reproducció del document publicat a:
It is part of: Nature Reviews Nephrology, 2020, vol. 16, num. 12, p. 747-764
Related resource:
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
NadimMK.pdf1.85 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons